|
|
Volumn 25, Issue 4, 2003, Pages 277-278
|
|
Robbing Peter to pay Paul? Financial reimbursement for chemotherapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ETOPOSIDE;
TOPOSAR;
CANCER CHEMOTHERAPY;
DRUG COST;
DRUG MARKETING;
EDITORIAL;
MEDICARE;
PRIORITY JOURNAL;
REIMBURSEMENT;
ANTINEOPLASTIC AGENTS;
COMPLICITY;
DECEPTION;
DRUG COSTS;
DRUG INDUSTRY;
DRUG UTILIZATION;
DRUG UTILIZATION REVIEW;
FRAUD;
HUMANS;
INSURANCE, HEALTH, REIMBURSEMENT;
MARKETING;
MEDICAL ONCOLOGY;
POLYPHARMACY;
PROFESSIONAL MISCONDUCT;
PUBLIC OPINION;
|
|
EID: 0037398878
PISSN: 10774114
EISSN: None
Source Type: Journal
DOI: 10.1097/00043426-200304000-00001 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|